<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/182481-a-process-for-preparing-a-synergistic-pharmaceutical-composition-for-delaying-cataractogenesis by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 04 Apr 2024 22:49:41 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 182481:A PROCESS FOR PREPARING A SYNERGISTIC PHARMACEUTICAL COMPOSITION FOR DELAYING CATARACTOGENESIS</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">A PROCESS FOR PREPARING A SYNERGISTIC PHARMACEUTICAL COMPOSITION FOR DELAYING CATARACTOGENESIS</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>* Abstract This Invention relates to a process for preparing a synergestic pharmaceutlcal composition for delaying cataractogenesls by blending amino acids, vitamins, antioxidants an d micro-sutrients like sodium selinlte in a given range.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td> <br><br><br><br>
This invention relates to a process for preparing a synergestic pharmaceutical composition for delaying cataractogenesis.<br>
Opacity of the lens of the eye as a result of degenerative changes in it causes cataract. Due to various factors the normally transparent crystalline lens of the eye becomes opaque which in turn impedes the light rays from entering the eye, result ing in gradual loss of vision or blindness. It has now been established that cataract formation which is largely due to ageing, can be delayed considerably by the intake of certain micro-nutrients, vitamins and minerals.<br>
Researchers have found that micro-nutrients like Riboflavin, Zinc, Selenium Iron and Copper are useful in delaying cataractogenesis. Recent studies have shown increased oxidative stress or activity in human metabolic system during the onset of browning of the lens during brunescent cataract. Introduction of antioxidant micro-nutrients as dietary supplement, delays the onset of oxidative degeneration of the lens. Intracellular and extracellular antioxidant propeties of vitamins like ascorbic acid, alphatocopherol and betacarotene have already been established by research studies. Deficiency of amino acids like phenylalanine, histidine, leucine, isoleucine, valine, threonine, lysine and methionine may also lead to lens degeneration, vascularization of cornea and resultant lens damage. Glycine and Lysine are also found to be important in delaying cataract onset in both normal and diabetic patients. The mechanism by which Lysine and Glycine work is by scavenging glucose resulting in the decrease  of  gtycat ion  of  lens  proteins.   Lysine,   glycine,<br><br>
glutamic acid and inositol exhibit antioxidant and antigIycating proper t i es, while alanine, ascorbic acid and pyridoxin show on 1y antigiycating properties. Tocopherol and carotenoids exhibit strong antioxidant properties.<br>
Deficiency of any of these nutrients hastens cat arac t'ogenesis in the elderly and the object of this invention is in providing a stable, synergestic and mutually compIimentary dietary supplement for delaying the onset of cataract. Adminstratjon of any of the above referred micro-nutrJents individually does not always produce the desired result of delaying cataractogenesis. We have found that a compos i t ion of micro-nutrients in a given range exhibits properties fundament ally different from the compound ing ingredients and shows synergistic and reinforced properties as these component s compliment each other in metabolic activity, glucose scavenging, and antioxidation. This composition is found effect!ve in delaying cataractogenesis in both normal and diabetic patients and is a dietary suppliment augmenting immunity and, promoting genera I heaIth.<br>
This invention relates to a process for preparing a synergistic pharmaceutical compos ition for del aying cataractogenesis which comprises blending compounds listed hereinunder in the ranges specified thereagainst with known adjuvants and/or excipients.<br>
L - Tryptophan	1.7 to 3.5 mg<br>
L - Valine	2.3 to 4.4 mg<br>
I. - Lysine	35 to 65 mg<br><br>
L - Phenylalanine	1.7 to 3.3 mg<br>
L - Histidine                    ,  1.4 to 3.3 mg<br>
L - Alanine	35 to 65 mg<br>
L-AsparticAcid	5.25to9.8mg<br>
Glycine	3.5to6.5 mg<br>
L - Giutatnic Acid	35 to 65 mg<br>
1, - Cysteine	5.25 to 12 mg<br>
Tocopherol Acetate	3.5 to 6.5 mg<br>
AscorbicAcid	I7to35 mg<br>
[nos i to I	35 to 65 mg<br>
Pyridoxin HcJ	1 to 2 mg<br>
Riboflavin	1 to 2 mg<br>
Copper Sulphate	0.3 to 0.6 mg<br>
Zinc Sulphate	5 to 10 mg<br>
Sodium Ketinite	17 to 33 meg<br>
Conventional additives, colorants and excipients are added depending upon the nature of the compos ition. If a liquid composition is preferred, adjuvants like distilled water and pharmaceutically acceptable solvents are used and the active ingredients specified above are either emuEsified or dissolved therein.<br>
Tablets or capsules are prepared by suitable substitution of so 1 id adjuvants. The compound ing ingredients may be thoroughly mixed and tabletted in the conventional manner. Capsules may also be formed wherien the active ingredients are spheronised and encapsulated in a shell made of pharmaceutically acceptable bio¬degradable material.<br><br>
Commonly  used  excipients or adjuvants  and  colorants  are given be low;<br>
Col. Tartrazine<br>
Col. Indigo Carmine<br>
Col. Erythrosine<br>
Col. Sunset Ye I low<br>
Titanium   Dioxide,  Lactose,  Potato  Starch,   Microcrystal1ine<br>
Cellulose,  Calcium  Carboxymethy1 Cellulose,  Methyl  Cellulose,<br>
Hydroxypropy1  Cellulose,  Polyethylene Glycol  6000,   Synthetic<br>
Aluminium  Silicate, Stearic acid. Industrial Methylated  Spirit,<br>
Polyvinyl  Pyrrolidone, Iso Propyl Alcohol and  Distilled  water,<br>
Maize Starch, Purified water.<br>
In a preferred embodiment, compat ib1e components of the composition are grouped together, spheronised, dried and encapsulated. For example, a capsule may contain a plurality of granules, the total composition of which falls within the range specifiecJ herein above, but each group of granules may contain a group of compatible components different from the other group. For instance, a capsule may contain whi te, yellow, red, chocolate blue, rose, green and orange granules of the composition specified herein below.<br>
Ye I 1ow Granules:<br>
- VaIine	3.35 mg<br>
, - Lysine He 1	62.5 mg<br>
. - Phenylalanine	2.5 mg<br>
. - Histidine Hcl	3.24 mg<br>
. - Alan ine	50.0 mg<br>
Glycine	5.00 mg<br><br>
Microcrystalline Cellulose	15.21 mg<br>
Potato Starch	15.0 mg<br>
Methyl Cellulose	4.75 mg<br>
Hydroxy Propyl Cellulose	1.0 mg<br>
Coi. Tartrazine	0.45 mg<br>
Water DistiHed	O.OJml<br>
The above components are mixed in a planetary mixer for one hour and water is added slowly to obtain a soft mass. This is passed through an extruder and then spheronlsed, using murmeriser. The spheronised granules are dried at 45° for about an hour till moisture content is reduced to less than 1%.<br>
H.  White Granules:<br>
Copper sulphate	0.42 mg<br>
Zinc su1phate	7.8 mg<br>
Rodium Selenite	25 meg<br>
Maize Starch	2R mg<br>
Micro Crystalline Cellulose	10 mg<br>
Methyl Cellulose	.1.8 mg<br>
Lactose	10 mg<br>
Water Purified	O.Ol ml<br>
The  above  ingredients  are mixed and granulated  as  stated  in connection with the preparation of Yellow Granules (No.I)<br>
11T.  Blue Granules:<br>
Ascorbic Acid	'	35 mg<br>
Stear i c Acid	1.05 mg<br>
Industrial Methylated Spirit       0.005 ml<br><br>
Potato Starch	3.65 mg<br>
Micro Crystalline Cellulose	1.75 mg<br>
Polyethylene Glycol 6000	1.2 mg<br>
Calcium Carboxy Methyl Cellulose   1.7 mg<br>
Methyl Cellulose	0.6 mg<br>
Co lour Ind i go Carmine	0.05 mg<br>
Water Purified	0.01 ml<br>
The above ingredients are blended and spheronised as stated under Yellow Granules (No.1)<br>
IV.  Rose Granules:<br>
Tocopherol Acetate	5.5 mg<br>
I. - Tryptophan        '	3-5 mg<br>
!, - Cystein	12.0 mg<br>
Synthetic Aluminium Silicate	4.0 mg<br>
Microcrystal1ine Cellulose	2.5 mg<br>
Polyethylene Glycol 6000	0.14 mg<br>
Hydroxy Propyl Cellulose	2.5 mg<br>
Calcium Carboxy Methyl Cellulose   2.7 mg<br>
Lactose	16.5 mg<br>
Colour Erythrosine	0.15 mg<br>
Colour Tartrazine	0.01 mg<br>
Water Purified	O.OI ml<br>
The above ingredients are mixed and; spheronised as stated  herein above.<br><br>
V.	Orange Granules:<br>
Inositol	60 iDg<br>
Pyridoxine Hcl	1.876 ng<br>
Riboflavin	1.876 mg<br>
Potato Starch	8.748 mg<br>
Microcrystal1ine Cellulose	10.0 mg<br>
Polyethylene Glycol 6000	0.5 mg<br>
Caiciun Carboxy Methyl Cellulose	6.0 mg<br>
Hydroxy Propyl Cellulose	1.0 mg<br>
Water Purified	0.01 ml<br>
The above ingredients are blended	and spheronised in a manner    as<br>
stated  herein  above.   Quantities of Vitamin mentioned  in  the<br>
process are inclusive of required	averages.<br>
VI,	Green Granules:<br>
L - Aspartic Acid	7.5 mg<br>
L - Glutamic Acid	SO mg<br>
Microcrystalline Cellulose	8.2 mg<br>
Potato Starch	8.02 mg<br>
Methyl Cellulose	4.0 mg<br>
Hydroxy Propyl Cellulose	0.5 mg<br>
Colour Tartrazine	0.2S mg<br>
Colour Indigo Carmine	0.03 mg<br>
Water Purified	0.01 ml<br>
Spheronised granules are made from the above  ingredients as stated hereinabove.<br><br>
VII. White Dummy	Granules:<br>
Lactose	47.52 mg<br>
Mai/e Starch	6.08 mg<br>
Microcrystal1ine	Cellulose	12.88 mg<br>
Methyl Cellulose	1.22 mg<br>
Water Purified	0.05 ml<br>
Dummy  Granu)es  are spheronised using the  above  quantities  of ingredients.<br>
Capsules  are prepared by mixing the desired  quantities  of granules under items 1 to 7 in the conventional manner.<br>
Obvious variations and equivalents are well witfiin the scope of this invention.<br>
I<br>
w<br><br><br><br>
We Claim:<br>
1- A process for preparing a synergistic pharmaceutica1 composition for delaying cataractogenesis compr ising blending compounds listed hereinunder in the ranges specified thereagainst with known adjuvants and/or excipients.<br>
L - Tryptophan	1.7 to 3.5 mg<br>
L - Valine	2.3 to 4.4 mg<br>
L - Lysine	35 to 65 mg<br>
L - Phenylalanine	1.7 to 3.3 mg<br>
L-Histidine	1.4to3.3mg<br>
L - Alanine	35 to 65 mg<br>
1,	- Aspartic Acid	5.25 to 9.8 mg<br>
Glycine	3.5to6.5mg<br>
L-GlutamicAcid	35to65 mg<br>
L - Cysteine	5.25 to 12 mg<br>
Tocopherol Acetate	3.5 to 6.5 mg<br>
Ascorbic Acid	17 to 35 mg<br>
Inositol	35 to 65 mg<br>
Pyridoxin Hcl	1 to 2 mg<br>
Riboflavin	1 to 2 mg<br>
Copper Sulphate	0.3 to 0.6 mg<br>
Zinc Sulphate	5 to 10 mg<br>
Sodium Selinide	17 to 33 meg<br>
2.	The process as claimed in claim 1, wherein the said<br>
compounds are blended to form an emulsion or suspension in known<br>
pharmaceutically acceptable adjuvants.<br><br>
3.	The process as claimed in claim 1 where in the compounds are tabletted after blending.<br>
4.	The process as claimed in claim I wherein the compounds are granulated and then encapsulated in a pharmaceutica1ly acceptable biodegradable casing.<br>
5.	The process as claimed in claims 1 to 4 wherein compatible compounds are blended together, spheronised to form granules, and then further blended before encapsulation.<br><br>
6.	The process as claimed in claims 1 &amp; 5 wherein pharmaceutically acceptable colorants are added.<br>
7.	The process as claimed in claims 5 &amp; 6 wherein different colorants are added to each group of spheronised granules.<br>
8.	The process as claimed in claims 5 to 7 wherein the granules<br>
are dried at 45 C to a moisture con tent of less than 1%.<br>
9.	A process for preparing a synergistic pharmaceutical<br>
composition for delaying cateractogenesis substantially as herein<br>
descr i bed.<br><br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjIzNC1tYXMtMTk5NyBhYnN0cmFjdC5wZGY=" target="_blank" style="word-wrap:break-word;">2234-mas-1997 abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjIzNC1tYXMtMTk5NyBjbGFpbXMucGRm" target="_blank" style="word-wrap:break-word;">2234-mas-1997 claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjIzNC1tYXMtMTk5NyBjb3JyZXNwb25kbmVjZS1vdGhlcnMucGRm" target="_blank" style="word-wrap:break-word;">2234-mas-1997 correspondnece-others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjIzNC1tYXMtMTk5NyBjb3JyZXNwb25kbmVjZS1wby5wZGY=" target="_blank" style="word-wrap:break-word;">2234-mas-1997 correspondnece-po.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjIzNC1tYXMtMTk5NyBkZXNjcmlwdGlvbihjb21wbGV0ZSkucGRm" target="_blank" style="word-wrap:break-word;">2234-mas-1997 description(complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjIzNC1tYXMtMTk5NyBmb3JtLTEucGRm" target="_blank" style="word-wrap:break-word;">2234-mas-1997 form-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjIzNC1tYXMtMTk5NyBmb3JtLTI2LnBkZg==" target="_blank" style="word-wrap:break-word;">2234-mas-1997 form-26.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="182280-process-for-the-crystallization-from-water-of-iopamidol-in-a-crystalline-anhydrous-form.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="182482-a-process-for-the-preparation-of-5-amino-2-4-6-triiodo-1-3-benzene-dicarboxylic-acid.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>182481</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>2234/MAS/1997</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>30/2009</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>24-Jul-2009</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>05-Nov-1999</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>08-Oct-1997</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>M/S. TABLETS (INDIA) LIMITED</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>179 TH ROAD, CHENNAI 600 081</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>RAJAGOPAL THIRUVENGADAM</td>
											<td>E-9, G.L.APT. 640TH ROAD, TONDIARPET, CHENNAI 600081</td>
										</tr>
										<tr>
											<td>2</td>
											<td>SHAIK MADHU SUHAN,</td>
											<td>E-9, G.L.APT. 640TH ROAD, TONDIARPET, CHENNAI 600081</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K31/195</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>N/A</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td></td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td></td>
									<td></td>
								    <td>NA</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/182481-a-process-for-preparing-a-synergistic-pharmaceutical-composition-for-delaying-cataractogenesis by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 04 Apr 2024 22:49:42 GMT -->
</html>
